Agizew Tefera, Basotli Joyce, Alexander Heather, Boyd Rosanna, Letsibogo Gaoraelwe, Auld Andrew, Nyirenda Sambayawo, Tedla Zegabriel, Mathoma Anikie, Mathebula Unami, Pals Sherri, Date Anand, Finlay Alyssa
Centers for Disease Control and Prevention, Gaborone, Botswana.
Centers for Disease Control and Prevention, Division of Global HIV and TB, Atlanta, Georgia, United States of America.
PLoS One. 2017 Dec 22;12(12):e0189981. doi: 10.1371/journal.pone.0189981. eCollection 2017.
Non-tuberculous mycobacteria (NTM) can cause pulmonary infection and disease especially among people living with HIV (PLHIV). PLHIV with NTM disease may clinically present with one of the four symptoms consistent with tuberculosis (TB). We describe the prevalence of NTM and Mycobacterium tuberculosis complex (MTBC) isolated among PLHIV who presented for HIV care and treatment.
All PLHIV patients presenting for HIV care and treatment services at 22 clinical sites in Botswana were offered screening for TB and were recruited. Patients who had ≥1 TB symptom were asked to submit sputa for Xpert MTB/RIF and culture. Culture growth was identified as NTM and MTBC using the SD-Bioline TB Ag MPT64 Kit and Ziehl Neelsen microscopy. NTM and MTBC isolates underwent species identification by the Hain GenoType CM and AS line probe assays.
Among 16, 259 PLHIV enrolled 3068 screened positive for at least one TB symptom. Of these, 1940 submitted ≥1 sputum specimen, 427 (22%) patients had ≥1 positive-culture result identified phenotypically for mycobacterial growth. Of these 247 and 180 patients were identified as having isolates were NTM and MTBC, respectively. Of the 247 patients identified with isolates containing NTM; 19 were later excluded as not having NTM based on additional genotypic testing. Among the remaining 408 patients 228 (56%, 95% confidence interval, 46-66%) with NTM. M. intracellulare was the most common isolated (47.8%). Other NTMs commonly associated with pulmonary disease included M. malmoense (3.9%), M. avium (2.2%), M. abscessus (0.9%) and M. kansasii (0.4%). After excluding NTM isolates that were non-speciated and M. gordonae 154 (67.5%) of the NTM isolates were potential pathogens.
In the setting of HIV care and treatment, over-half (56%) of a positive sputum culture among PLHIV with TB symptoms was NTM. Though we were not able to distinguish in our study NTM disease and colonization, the study suggests culture and species identification for PLHIV presenting with TB symptoms remains important to facilitate NTM diagnosis and hasten time to appropriate treatment.
非结核分枝杆菌(NTM)可引起肺部感染和疾病,尤其是在艾滋病病毒感染者(PLHIV)中。患有NTM疾病的PLHIV在临床上可能表现出与结核病(TB)一致的四种症状之一。我们描述了在接受艾滋病护理和治疗的PLHIV中分离出的NTM和结核分枝杆菌复合群(MTBC)的患病率。
在博茨瓦纳22个临床地点接受艾滋病护理和治疗服务的所有PLHIV患者均接受了结核病筛查并被招募。有≥1种结核症状的患者被要求提交痰液进行Xpert MTB/RIF检测和培养。使用SD-Bioline TB Ag MPT64试剂盒和萋-尼氏显微镜检查将培养生长物鉴定为NTM和MTBC。NTM和MTBC分离株通过Hain GenoType CM和AS线探针检测进行菌种鉴定。
在16259名登记的PLHIV中,3068人至少有一种结核症状筛查呈阳性。其中,1940人提交了≥1份痰标本,427名(22%)患者有≥1份培养结果表型鉴定为分枝杆菌生长阳性。其中,分别有247名和180名患者的分离株被鉴定为NTM和MTBC。在247名鉴定为含有NTM分离株的患者中;根据额外的基因检测,19人后来被排除为没有NTM。在其余408名患者中,228名(56%,95%置信区间,46-66%)患有NTM。胞内分枝杆菌是最常见的分离株(47.8%)。其他通常与肺部疾病相关的NTM包括马尔默分枝杆菌(3.9%)、鸟分枝杆菌(2.2%)、脓肿分枝杆菌(0.9%)和堪萨斯分枝杆菌(0.4%)。在排除未鉴定物种的NTM分离株和戈登分枝杆菌后,154名(67.5%)NTM分离株为潜在病原体。
在艾滋病护理和治疗环境中,有结核症状的PLHIV中痰培养阳性的超过一半(56%)是NTM。尽管我们在研究中无法区分NTM疾病和定植,但该研究表明,对有结核症状的PLHIV进行培养和菌种鉴定对于促进NTM诊断和加快获得适当治疗的时间仍然很重要。